APG Asset Management N.V. Acquires 74,743 Shares of HCA Healthcare, Inc. (NYSE:HCA)

APG Asset Management N.V. increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 64.0% during the second quarter, HoldingsChannel reports. The institutional investor owned 191,475 shares of the company’s stock after buying an additional 74,743 shares during the quarter. APG Asset Management N.V.’s holdings in HCA Healthcare were worth $57,399,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. MFA Wealth Advisors LLC acquired a new stake in HCA Healthcare during the second quarter worth about $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare during the second quarter valued at approximately $28,000. Bangor Savings Bank boosted its holdings in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC lifted its position in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares during the last quarter. Finally, LifeSteps Financial Inc. bought a new position in HCA Healthcare in the first quarter valued at about $33,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $404.06 on Friday. The firm’s 50-day moving average price is $375.64 and its 200-day moving average price is $342.20. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $409.42. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The firm has a market capitalization of $105.83 billion, a P/E ratio of 20.14, a P/E/G ratio of 1.52 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same quarter in the prior year, the company posted $4.29 earnings per share. The business’s revenue was up 10.3% on a year-over-year basis. Equities research analysts anticipate that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

Insider Activity at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,202 shares of company stock worth $6,407,273. Insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HCA. JPMorgan Chase & Co. raised their target price on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a research report on Thursday, May 30th. Robert W. Baird assumed coverage on HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 price target on the stock. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research report on Monday, August 19th. Finally, UBS Group boosted their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.